IDiyas

For the Inventor, By the Inventor

Waltham, MA, United States of America

Praveen Mudunuri

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 7.9

ph-index = 6

Forward Citations = 441(Granted Patents)


Location History:

  • Watertown, MA (US) (2012)
  • Waltham, MA (US) (2013 - 2020)

Company Filing History:

goldMedal9 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal2 out of 44 
 
Alios Biopharma, Inc.
 patents

Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 10716789 - Co-crystals and pharmaceutical compositions comprising the same (2020-07-21),
2. 10039761 - Co-crystals and pharmaceutical compositions comprising the same (2018-08-07),
3. 9856284 - Solid forms of a thiophosphoramidate nucleotide prodrug (2018-01-02),
4. 9771361 - Inhibitors of influenza viruses replication (2017-09-26),
5. 9394330 - Solid forms of a thiophosphoramidate nucleotide prodrug (2016-07-19),
6. 8916538 - Solid forms of a thiophosphoramidate nucleotide prodrug (2014-12-23),
7. 8785476 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2014-07-22),
8. 8623894 - Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide (2014-01-07),
9. 8471029 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2013-06-25),
10. 8362253 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2013-01-29),
11. 8163772 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2012-04-24),

Title: Praveen Mudunuri: Innovator in Co-Crystal Pharmaceutical Compositions

Introduction

Praveen Mudunuri, an accomplished inventor based in Waltham, MA, has made significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has demonstrated a strong commitment to innovation and the development of advanced pharmaceutical compositions.

Latest Patents

Among his prominent inventions is the patent for co-crystals and pharmaceutical compositions comprising the same. This invention relates to compositions and co-crystals that include a compound of a specific formula, wherein each of the R groups may be hydrogen or another specified group. The co-crystal formers can include substances such as adipic acid, citric acid, fumaric acid, maleic acid, succinic acid, or benzoic acid. The invention also encompasses methods of making and utilizing these compositions, showcasing Praveen's ingenuity in pharmaceutical science.

Career Highlights

Throughout his career, Praveen Mudunuri has worked with leading companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Alios Biopharma, Inc. His experience in these organizations highlights his role in advancing medical research and contributing to innovative drug development.

Collaborations

Praveen has collaborated with talented professionals in his field, including Ales Medek and Michael Waldo. These collaborations reflect the collective effort of dedicated individuals working together to push the boundaries of pharmaceutical innovation.

Conclusion

Praveen Mudunuri's contributions to the field of pharmaceuticals through his numerous patents emphasize his role as a leading inventor. His work with co-crystals and the development of unique pharmaceutical compositions continue to impact the industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…